• No se han encontrado resultados

[PDF] Top 20 Clinical response in patients with ovarian cancer treated with metronomic chemotherapy

Has 10000 "Clinical response in patients with ovarian cancer treated with metronomic chemotherapy" found on our website. Below are the top 20 most common "Clinical response in patients with ovarian cancer treated with metronomic chemotherapy".

Clinical response in patients with ovarian cancer treated with  metronomic chemotherapy

Clinical response in patients with ovarian cancer treated with metronomic chemotherapy

... the chemotherapy schemes, but also on others factors like response to first line chemotherapy, disease free survival upon surgery, and number of previous treatments ...[22]. Metronomic ... See full document

10

Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients

Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients

... implicated in multiple stages throughout the tumorigenic process [13], and that is over- expressed in a variety of malignancies including breast cancer, at variance with COX-1, which is ... See full document

27

SEOM Clinical Guideline of localized rectal cancer (2016).

SEOM Clinical Guideline of localized rectal cancer (2016).

... For patients with locally recurrent rectal cancer fol- lowing high-dose pelvic radiation, management decisions have generally been directed toward palliative care or chemotherapy ... See full document

9

Predicting response and survival in chemotherapy-treated triple-negative breast cancer.

Predicting response and survival in chemotherapy-treated triple-negative breast cancer.

... summarised in Table 1. The neoadjuvant cohorts had pathological complete response (pCR) in the breast (GEICAM/2006-03) and breast and axilla (MDACC based) as the primary end ...points. ... See full document

10

The Immune Response and the Therapeutic Effect of Metronomic Chemotherapy With Cyclophosphamide

The Immune Response and the Therapeutic Effect of Metronomic Chemotherapy With Cyclophosphamide

... Metronomic chemotherapy (MCT) is a novel therapeutic strategy for cancer treatment endowed with an antiangiogenic ...drugs, with minimal or no drug-free ...MCT with Cy on ... See full document

6

Metastatic breast cancer patients treated with low dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response

Metastatic breast cancer patients treated with low dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response

... Metronomic chemotherapy (MCT) poses a new paradigm in cancer therapy: “less is more when administered chronically” ...demonstrated in pre-clinical and clinical studies, ... See full document

25

Association between baseline VEGF/sVEGFR 2 and VEGF/TSP 1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer

Association between baseline VEGF/sVEGFR 2 and VEGF/TSP 1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer

... along with the individual molecules, for its value as predictors of response to ...those patients who are prone to be benefited by ...of patients is needed to validate, or eliminate it as a ... See full document

7

Individualización del tratamiento en el tumor vesical no músculo-invasivo según criterios clínicos y anatomopatológicos

Individualización del tratamiento en el tumor vesical no músculo-invasivo según criterios clínicos y anatomopatológicos

... 1cm in size). Despite being a group of patients with low-risk tumours, in whom the yield of urine cytology is expected to be low [10], in our series ...of patients dropped out of ... See full document

152

Use of Functional Foods and Oral Supplements as Adjuvants in Cancer Treatment

Use of Functional Foods and Oral Supplements as Adjuvants in Cancer Treatment

... In cancer patients treated with radiotherapy to the abdominopelvic region, dietary modifications and the use of functional foods (fortified food with added ingredients to provide ... See full document

11

Variación diurna del cortisol y su relación con estrés, optimismo y estrategias de afrontamiento en mujeres con cáncer de mama

Variación diurna del cortisol y su relación con estrés, optimismo y estrategias de afrontamiento en mujeres con cáncer de mama

... affected in patients with ...differences in cortisol levels in women with breast cancer in different stages and analyze the relationship between cortisol levels and ... See full document

10

TítuloEstudio de la transferencia directa para angioplastia primaria en pacientes con infarto de miocardio con elevación del segmento ST : efecto en los retrasos temporales y en el pronóstico

TítuloEstudio de la transferencia directa para angioplastia primaria en pacientes con infarto de miocardio con elevación del segmento ST : efecto en los retrasos temporales y en el pronóstico

... Field triage reduces treatment delay and improves long-term clinical outcome in patients with acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary [r] ... See full document

214

Test de seguridad y efectividad en el control de fluidos y distribución del fármaco durante el desarrollo de un modelo de acceso laparoscópico para cirugía citorreductora y uso de paclitaxel en cavidad abdominal hipertérmica mediante un sistema cerrado co

Test de seguridad y efectividad en el control de fluidos y distribución del fármaco durante el desarrollo de un modelo de acceso laparoscópico para cirugía citorreductora y uso de paclitaxel en cavidad abdominal hipertérmica mediante un sistema cerrado con recirculación de CO2 en un modelo experimental porcino

... Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy HIPEC: Rationale and Design of the PERISCOPE Stu[r] ... See full document

304

Determinación de interleucina-10 (IL-10) en pacientes con cáncer en estadios III y IV tratados con dexametasonaDetermination Of Interleukine-10 In Cancer Patients In Stages Iii And Iv Treated With Dexamethasone.

Determinación de interleucina-10 (IL-10) en pacientes con cáncer en estadios III y IV tratados con dexametasonaDetermination Of Interleukine-10 In Cancer Patients In Stages Iii And Iv Treated With Dexamethasone.

... description Dexamethasone treatment in patients with cancer in stages III and IV is associated with immune response.. suppression, possibly because of the inhibiting effect produced by a[r] ... See full document

3

Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.

Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.

... with the ASCO Conflict of Interest Management Procedures for Clinical Practice Guidelines, reviewed the abstracts that were identified for predefined signals that would suggest the need to change a previous ... See full document

5

Predictores evolucin quirrgica adversa de pacientes con obstruccin intestinal maligna

Predictores evolucin quirrgica adversa de pacientes con obstruccin intestinal maligna

... pathologic, clinical and surgical data were ...associated with morbidity and mor- tality were analyzed with the Pearson chi-square test and Student’s t ...constructed with the Kaplan-Meier ... See full document

5

TítuloEnzalutamide: a new prostate cancer targeted therapy against the androgen receptor

TítuloEnzalutamide: a new prostate cancer targeted therapy against the androgen receptor

... enzalutamide in patients with progressive metastatic CRPC (mCRPC). In this study, 140 patients were enrolled in dose-escalation cohorts of 3-6 patients starting ... See full document

13

Pulmonary Vasoreactivity and Phenotypes in Pulmonary Arterial Hypertension Associated to Connective Tissue Diseases

Pulmonary Vasoreactivity and Phenotypes in Pulmonary Arterial Hypertension Associated to Connective Tissue Diseases

... evaluated with the Kolmogorov–Smirnov and the Shapiro–Wilk ...formed with Student's t-test and Wilcoxon's ranked sum test and the comparison of categorical variables were performed with Chi-square ... See full document

6

Depression in Terminally Patients.pdf

Depression in Terminally Patients.pdf

... ill cancer pa- tients receiving aggressive, inpatient pal- liative care, we found substantial rates of clinical depression (17%) and desire for hastened death ...pared with nondepressed ... See full document

5

Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa

Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa

... specialized in the treatment of advanced PD with LCIG, who based their recommendations on the available literature (indicated with refer- ences), the protocols of their work centers (coded as P) and ... See full document

16

Nodular Regenerative Hyperplasia Induced by Trastuzumab Emtansine: Role of Emtansine?

Nodular Regenerative Hyperplasia Induced by Trastuzumab Emtansine: Role of Emtansine?

... 2015, clinical examination showed a hepatosplenomegaly with mildly disturbed liver func- tion tests: increase of transaminases was less than to 2- fold the upper limit of ...normal). In January 2016, ... See full document

5

Show all 10000 documents...